Original Research
Published on 22 Jul 2024
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study
in Neuromuscular Disorders and Peripheral Neuropathies
- 12,525 views
- 15 citations










